Back to search
Infantile Spinal Muscular Atrophy of Type 2 or 3
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infantile Spinal Muscular Atrophy of Type 2 or 3 trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Infantile Spinal Muscular Atrophy of Type 2 or 3 trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 3, open-label, single-arm, single-dose, trial of onasemnogene abeparvovec-xioi (gene replacement therapy) in participants with spinal muscular a…
This clinical trial aims to test a new physio-therapeutic approach tailored to type 2 and 3 Spinal Muscular Atrophy patients, based on physical training in swim…